Detalhe da pesquisa
1.
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non-small-cell lung cancer.
Int J Cancer
; 154(9): 1607-1615, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196128
2.
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer.
Cancer Sci
; 114(11): 4343-4354, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715310
3.
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1.
Int J Clin Oncol
; 28(10): 1354-1368, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548831
4.
Identification of targetable kinases in idiopathic pulmonary fibrosis.
Respir Res
; 23(1): 20, 2022 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130915
5.
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
Int J Clin Oncol
; 27(7): 1139-1144, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35534642
6.
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA.
Int J Clin Oncol
; 27(4): 695-706, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35182247
7.
COVID-19 Vaccine-Associated Lymphadenopathy Mimicking Regrowth of Axillary Lymph Node Metastasis of Lung Adenocarcinoma.
Acta Med Okayama
; 76(5): 593-596, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36352807
8.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol
; 22(1): 51-65, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285097
9.
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers.
Cancer Sci
; 112(5): 1853-1864, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33410241
10.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Cancer Sci
; 112(12): 5000-5010, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543477
11.
Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors.
Cancer Immunol Immunother
; 70(1): 101-106, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32648165
12.
Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301.
BMC Cancer
; 21(1): 506, 2021 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957881
13.
A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.
Jpn J Clin Oncol
; 51(6): 956-965, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829270
14.
Impact of previous thoracsic radiation therapy on the efficacy of immune checkpoint inhibitors in advanced non-smasll-cell lung cancer.
Jpn J Clin Oncol
; 51(2): 279-286, 2021 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33049757
15.
Survival of chemo-naïve patients with EGFR mutation-positive advanced non-small cell lung cancer after treatment with afatinib and bevacizumab: updates from the Okayama Lung Cancer Study Group Trial 1404.
Jpn J Clin Oncol
; 51(8): 1269-1276, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34115855
16.
A randomized trial of sodium alginate prevention of esophagitis in LA-NSCLC receiving chemoradiotherapy: OLCSG1401.
Support Care Cancer
; 29(9): 5237-5244, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33649919
17.
First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis.
Int J Clin Oncol
; 26(6): 1073-1082, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826027
18.
Protocol for a multi-site, cluster-randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non-small-cell lung cancer: the ENSURE-GA study.
BMC Geriatr
; 21(1): 74, 2021 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482741
19.
Utility of immune checkpoint inhibitors in non-small-cell lung cancer patients with poor performance status.
Cancer Sci
; 111(10): 3739-3746, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726470
20.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Cancer Sci
; 111(12): 4480-4489, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926507